Please indicate country of residence below or click here to return.
You are not legally authorized to access this document.
Please read the following notice carefully before deciding whether to click on the link below.
|
Q3 |
Q3 |
Q1-Q3 |
Q1-Q3 |
| ||
|
|
2009 |
2008 |
2009 |
2008 |
FY 2008 | |
|
|
|
| ||||
|
Turnover |
EUR '000 |
826 |
- |
2,604 |
- |
- |
|
Operating profit (loss) |
EUR '000 |
(15,303) |
(4,955) |
(23,208) |
(9,576) |
(4,296) |
|
Profit (loss) before taxes |
EUR '000 |
(15,314) |
(9,001) |
(30,003) |
(13,452) |
(8,033) |
|
Earnings per share |
EUR |
(0.04) |
(0.03) |
(0.08) |
(0.05) |
0.03 |
|
Capital expenditure |
EUR '000 |
24,315 |
100,128 |
82,052 |
273,030 |
429,086 |
|
Net interest-bearing debt |
EUR '000 |
354,130 |
100,131 |
354,130 |
100,131 |
285,467 |
|
Debt-to-equity ratio |
84.2 % |
28.3 % |
84.2 % |
28.3 % |
67.3 % | |
|
Cash and cash equivalents
at the end of the period |
EUR '000 |
68,624 |
93,028 |
68,624 |
93,028 |
82,713 |
|
Derivative financial instruments |
EUR '000 |
64,975 |
74,393 |
64,975 |
74,393 |
152,545 |
|
Number of employees at the
end of the period |
283 |
229 |
283 |
229 |
239 |
|
|
|
Q3 2009 |
Q1-Q3 2009 |
2008-2009 |
|
Mining |
||||
|
Blasted ore |
million tonnes |
2.0 |
7.3 |
10.3 |
|
Excavated waste |
million tonnes |
1.0 |
2.9 |
4.2 |
|
Materials handling |
||||
|
Stacked ore |
million tonnes |
1.4 |
5.5 |
8.0 |
|
Bioheapleaching |
||||
|
Ore in primary heap
at end of period |
million tonnes |
8.0 |
8.0 |
8.0 |
|
Metals recovery |
||||
|
Nickel sulphide production |
dry metric tonnes |
208 |
668 |
668 |
|
Nickel metal content |
tonnes |
101 |
325 |
325 |
|
Zinc sulphide production |
dry metric tonnes |
190 |
1,444 |
1,444 |
|
Zinc metal content |
tonnes |
114 |
820 |
820 |
|
|
|||||
|
Unaudited three |
Unaudited three |
Unaudited nine |
Unaudited nine |
Audited twelve | |
|
months to |
months to |
months to |
months to |
months to | |
|
(all amounts in EUR '000) |
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 |
|
Turnover |
826 |
- |
2,604 |
- |
- |
|
Other operating income |
11,599 |
3,402 |
37,152 |
12,568 |
29,810 |
|
Changes in inventories of finished goods and work in progress |
15,100 |
3,773 |
47,177 |
3,773 |
24,006 |
|
Materials and services |
(12,763) |
(4,389) |
(40,267) |
(5,910) |
(20,407) |
|
Employee benefit expenses |
(3,566) |
(3,159) |
(11,631) |
(7,286) |
(8,910) |
|
Depreciation, amortization, depletion and impairment charges |
(9,458) |
(265) |
(25,677) |
(462) |
(5,756) |
|
Other operating expenses |
(17,041) |
(4,317) |
(32,566) |
(12,259) |
(23,039) |
|
Operating profit (loss) |
(15,303) |
(4,955) |
(23,208) |
(9,576) |
(4,296) |
|
Finance income |
8,026 |
514 |
15,039 |
2,799 |
9,219 |
|
Finance cost |
(8,037) |
(4,560) |
(21,834) |
(6,675) |
(12,956) |
|
Finance cost (net) |
(11) |
(4,046) |
(6,795) |
(3,876) |
(3,737) |
|
Loss before income tax |
(15,314) |
(9,001) |
(30,003) |
(13,452) |
(8,033) |
|
|
|||||
|
Income tax expense |
4,565 |
(363) |
8,056 |
(1,895) |
13,865 |
|
Profit (loss) for the period |
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 |
|
Attributable to: |
|||||
|
Equity holders of the Company |
(9,310) |
(7,013) |
(18,415) |
(10,975) |
7,042 |
|
Minority interest |
(1,439) |
(2,351) |
(3,532) |
(4,372) |
(1,210) |
|
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 | |
|
Earnings per share for profit (loss) attributable to the equity holders of the Company (expressed in per share) |
|||||
|
Basic and diluted |
(0.04) |
(0.03) |
(0.08) |
0.05) |
0.03 |
|
|
|||||
|
Unaudited three |
Unaudited three |
Unaudited nine |
Unaudited nine |
Audited twelve | |
|
months to |
months to |
months to |
months to |
months to | |
|
(all amounts in EUR '000) |
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 |
|
|
|
|
|
| |
|
Profit (loss) for the period |
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 |
|
|
|
|
|
| |
|
Other comprehensive income, |
|||||
|
items net of tax |
|
|
|
|
|
|
Available-for-sale financial assets |
- |
- |
- |
(451) |
(451) |
|
Cash flow hedges |
(16,461) |
32,331 |
(63,828) |
42,637 |
90,414 |
|
Other comprehensive income, net of tax |
(16,461) |
32,331 |
(63,828) |
42,186 |
89,963 |
|
|
|||||
|
Total comprehensive income |
(27,210) |
22,967 |
(85,775) |
26,839 |
95,795 |
|
Attributable to: |
|||||
|
Equity holders of the Company |
(22,479) |
18,853 |
(69,478) |
22,685 |
78,922 |
|
Minority interest |
(4,731) |
4,114 |
(16,297) |
4,154 |
16,873 |
|
|
(27,210) |
22,967 |
(85,775) |
26,839 |
95,795 |
|
|
|
||
|
Unaudited |
Audited |
Unaudited | |
|
(all amounts in EUR '000) |
30 Sep 09 |
31 Dec 08 |
30 Sep 08 |
|
|
|||
|
ASSETS |
|||
|
Non-current assets |
|||
|
Property, plant and equipment |
615,195 |
552,459 |
401,794 |
|
Biological assets |
6,368 |
8,152 |
8,249 |
|
Intangible assets |
7,609 |
7,774 |
7,164 |
|
Deferred tax assets |
7,412 |
- |
|
|
Derivative financial instruments |
39,391 |
116,004 |
61,355 |
|
Other receivables |
11,227 |
9,635 |
10,119 |
|
687,202 |
694,024 |
488,681 | |
|
Current assets |
|||
|
Inventories |
82,080 |
31,691 |
4,803 |
|
Trade receivables |
981 |
- |
- |
|
Other receivables |
10,609 |
24,721 |
19,500 |
|
Derivative financial instruments |
30,413 |
40,805 |
13,700 |
|
Cash and cash equivalent |
68,624 |
82,713 |
93,028 |
|
192,707 |
179,930 |
131,031 | |
|
Total assets |
879,909 |
873,954 |
619,712 |
|
EQUITY AND LIABILITIES |
|||
|
|
|||
|
Equity attributable to equity holders of the parent |
|||
|
Share capital |
80 |
80 |
80 |
|
Share premium |
8,086 |
8,086 |
8,086 |
|
Other reserves |
416,554 |
334,019 |
333,533 |
|
Hedge reserve |
21,269 |
72,332 |
34,111 |
|
Retained earnings |
(44,516) |
(26,101) |
(44,119) |
|
401,473 |
388,416 |
331,691 | |
|
Minority interest in equity |
19,119 |
35,470 |
22,745 |
|
Total equity |
420,592 |
423,886 |
354,436 |
|
|
|||
|
Non-current liabilities |
|||
|
Borrowings |
412,852 |
367,955 |
193,135 |
|
Derivative financial instruments |
3,487 |
1,985 |
662 |
|
Deferred tax liabilities |
- |
23,070 |
22,044 |
|
Provisions |
1,018 |
944 |
423 |
|
417,357 |
393,954 |
216,264 | |
|
Current liabilities |
|||
|
Borrowings |
9,912 |
224 |
25 |
|
Trade payables |
19,401 |
45,283 |
41,819 |
|
Other payables |
11,305 |
8,294 |
7,134 |
|
Derivative financial instruments |
1,342 |
2,279 |
- |
|
Provisions |
- |
34 |
34 |
|
41,960 |
56,114 |
49,012 | |
|
Total liabilities |
459,317 |
450,068 |
265,276 |
|
Total equity and liabilities |
879,909 |
873,954 |
619,712 |
|
|
||||||
|
Unaudited
three |
Unaudited three |
Unaudited nine |
Unaudited nine |
Audited twelve | ||
|
months to |
months to |
months to |
months to |
months to | ||
|
(all amounts in EUR '000) |
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 | |
|
Cash flows from operating activities |
||||||
|
|
||||||
|
Profit (loss) for the period |
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 | |
|
Adjustments for |
||||||
|
Tax |
(4,565) |
363 |
(8,056) |
1,895 |
(13,865) | |
|
Depreciation and amortization |
9,458 |
265 |
25,677 |
462 |
5,756 | |
|
Other non-cash income and expenses |
603 |
922 |
3,327 |
2,430 |
4,780 | |
|
Interest income |
(8,026) |
(514) |
(15,039) |
(2,799) |
(9,219) | |
|
Fair value gains on financial assets at fair value through profit or loss |
10,996 |
(3,003) |
2,806 |
(7,604) |
(24,796) | |
|
Interest expense |
8,037 |
4,560 |
21,834 |
6,675 |
12,956 | |
|
5,754 |
(6,771) |
8,602 |
(14,288) |
(18,556) | ||
|
Change in working capital |
||||||
|
Decrease(+)/increase(-) in other receivables |
2,533 |
9,239 |
9,314 |
12,537 |
4,552 | |
|
Decrease (+)/increase (-) in inventories |
(16,404) |
(4,803) |
(51,122) |
(4,803) |
(30,661) | |
|
Decrease(-)/increase(+) in trade and other payables |
1,783 |
2,154 |
(24,072) |
18,670 |
23,773 | |
|
Change in working capital |
(12,088) |
6,590 |
(65,880) |
26,404 |
(2,336) | |
|
(6,334) |
(181) |
(57,278) |
12,116 |
(20,892) | ||
|
Interest and other finance cost paid |
(4,578) |
(1,169) |
(16,132) |
(4,855) |
(7,468) | |
|
Interest income |
52 |
501 |
3,430 |
956 |
9,581 | |
|
Net cash used in operating activities |
(10,860) |
(849) |
(69,980) |
8,217 |
(18,779) | |
|
Cash flows from investing activities |
||||||
|
|
||||||
|
Acquisition of subsidiary, net of cash acquired |
(54) |
- |
(54) |
- |
- | |
|
Purchases of property, plant and equipment |
(24,182) |
(100,045) |
(81,842) |
(271,802) |
(427,187) | |
|
Purchases of biological assets |
- |
- |
(35) |
(26) |
(26) | |
|
Purchases of intangible assets |
(133) |
(83) |
(175) |
(1,202) |
(1,873) | |
|
Proceeds from sale of property, plant and equipment |
- |
- |
9 |
- |
- | |
|
Proceeds from sale of intangible assets |
- |
- |
49 |
- |
- | |
|
Proceeds from sale of biological assets |
104 |
124 |
104 |
251 |
707 | |
|
Proceeds from government grant related to tangible assets |
- |
- |
5,000 |
- |
- | |
|
Proceeds from government grant related to intangible assets |
- |
204 |
13 |
204 |
203 | |
|
Proceeds from sale of available for sale financial assets |
- |
- |
- |
26,356 |
26,356 | |
|
Purchases of derivative financial instruments |
- |
- |
(1,371) |
(1,371) | ||
|
Proceeds from sale of derivative financial instruments |
- |
- |
- |
- |
- | |
|
Proceeds from sale of financial assets at fair value through |
||||||
|
profit or loss |
- |
- |
- |
1,440 |
1,440 | |
|
Net cash used in investing activities |
(24,265) |
(99,800) |
(76,931) |
(246,150) |
(401,751) | |
|
Cash flows from financing activities |
||||||
|
Proceeds from share issue net of transaction costs |
80,644 |
- |
80,644 |
- |
- | |
|
Proceeds from interest-bearing liabilities |
- |
119,560 |
53,357 |
204,460 |
396,734 | |
|
Payment of interest-bearing liabilities |
(1,154) |
- |
(1,179) |
- |
(20,000) | |
|
Capital investment by minority shareholders |
- |
- |
- |
- |
8 | |
|
Net cash generated in financing activities |
79,490 |
119,560 |
132,822 |
204,460 |
376,742 | |
|
|
||||||
|
Net (decrease)/increase in cash and bank overdrafts |
44,365 |
18,911 |
(14,089) |
(33,473) |
(43,788) | |
|
|
||||||
|
Cash and bank overdrafts at beginning of the period |
24,259 |
74,117 |
82,713 |
126,501 |
126,501 | |
|
Cash and bank overdrafts at end of the period |
68,624 |
93,028 |
68,624 |
93,028 |
82,713 | |
|
A |
B |
C |
D |
E |
F |
G |
H |
I | |||
|
Balance at 1 January 2008
|
16
|
8,086
|
320,671
|
1,106
|
-
|
(33,423)
|
296,456
|
18,591
|
315,047
| ||
|
Total comprehensive
income for 1-9/2008 |
- |
- |
- |
(451) |
34,111 |
(10,975) |
22,685 |
4,154 |
26,839 | ||
|
Transfers within equity,
change of the corporate form |
64 |
- |
(64) |
- |
- |
- |
- |
- |
- | ||
|
Employee share option
scheme |
|||||||||||
|
- value of employee
services |
- |
- |
- |
1,377 |
- |
- |
1,377 |
- |
1,377 | ||
|
Convertible bond,
equity component |
- |
- |
- |
10,894 |
- |
- |
10,894 |
- |
10,894 | ||
|
Restatement to capital
expenditure, which
relates to
previous year |
- |
- |
- |
- |
- |
278 |
278 |
- |
278 | ||
|
Minority interest arising
from subsidiary |
- |
- |
- |
- |
- |
1 |
1 |
- |
1 | ||
|
Balance at 30
September 2008 |
80 |
8,086 |
320,607 |
12,926 |
34,111 |
(44,119) |
331,691 |
22,745 |
354,436 | ||
|
|
|
|
|
|
|
|
|
|
| ||
|
Balance at 31
December 2008 |
80 |
8,086 |
320,607 |
13,412 |
72,332 |
(26,101) |
388,416 |
35,470 |
423,886 | ||
|
|
|
|
|
|
|
|
|
|
| ||
|
Balance at 1
January 2009 |
80 |
8,086 |
320,607 |
13,412 |
72,332 |
(26,101) |
388,416 |
35,470 |
423,886 | ||
|
Total comprehensive
income for
1-9/2009 |
- |
- |
- |
- |
(51 063) |
(18 415) |
(69 478) |
(16 297) |
(85 775) | ||
|
Share issue,
net of transaction
costs |
- |
- |
82,691 |
- |
- |
- |
82,691 |
- |
82,691 | ||
|
External costs
directly
attributable to |
|||||||||||
|
The issue of
new shares |
- |
- |
(2,047) |
- |
- |
- |
(2,047) |
- |
(2,047) | ||
|
Acquisition of
subsidiary, Hyena
Holding AB |
- |
- |
- |
- |
- |
- |
- |
(54) |
(54) | ||
|
Employee share
option scheme |
|||||||||||
|
- value of employee
services |
- |
- |
- |
1,891 |
- |
- |
1,891 |
- |
1,891 | ||
|
Balance at 30
September 2009 |
80 |
8,086 |
401,251 |
15,303 |
21,269 |
(44,516) |
401,473 |
19,119 |
420,592 | ||
|
Inventories |
||
|
|
||
|
(all amounts in EUR '000) |
Unaudited |
Audited |
|
|
30 September |
31 December |
|
|
2009 |
2008 |
|
Raw materials and consumables |
8 819 |
6 655 |
|
Ore on leach pads |
43 911 |
22 965 |
|
Work in progress |
26 225 |
1 041 |
|
Finished products |
1 047 |
- |
|
Advance payments |
2 078 |
1 030 |
|
Inventories total |
82 080 |
31 691 |
|
Derivative financial instruments |
||||||
|
|
||||||
|
Fair values of the derivative financial instruments |
||||||
|
|
||||||
|
(all amounts in EUR '000) |
Unaudited |
Audited |
||||
|
30 September |
31 December |
|||||
|
|
2009 |
2008 |
||||
|
Assets |
Liabilities |
Assets |
Liabilities |
|||
|
|
|
|
|
|||
|
Nickel forwards - cash flow hedges |
46,418 |
- |
135,355 |
- |
||
|
Nickel forwards - held for trading |
7,621 |
- |
3,301 |
- |
||
|
Zinc forwards - held for trading |
122 |
940 |
18,153 |
- |
||
|
Interest rate swaps - held for trading |
- |
3,100 |
- |
2,279 |
||
|
Currency forwards - held for trading |
15,643 |
- |
- |
- |
||
|
Currency options - held for trading |
- |
789 |
- |
1,985 |
||
|
Total |
69,804 |
4,829 |
156,809 |
4,264 |
||
|
Unaudited |
Audited | |||||
|
30 September |
31 December | |||||
|
2009 |
2008 | |||||
|
Assets |
Liabilities |
Assets |
Liabilities | |||
|
Derivative financial instruments |
69,804 |
4,829 |
156,809 |
4,264 | ||
|
Total |
69,804 |
4,829 |
156,809 |
4,264 | ||
|
Less non-current portion |
|
|
|
| ||
|
Nickel forwards - cash flow hedges |
29,860 |
- |
101,797 |
- | ||
|
Nickel forwards - held for trading |
- |
- |
- |
- | ||
|
Zinc forwards - held for trading |
9 |
387 |
14,207 |
- | ||
|
Interest rate swaps - held for trading |
- |
3,100 |
- |
1,985 | ||
|
Currency forwards - held for trading |
9,522 |
- |
- |
- | ||
|
Current portion |
30,413 |
1,342 |
40,805 |
2,279 | ||
|
Quantities of the derivative financial instruments
|
||||||
|
|
Unaudited |
Audited |
||||
|
30 Sep 2009 |
Total |
31 Dec 2008 |
Total | |||
|
Current |
Non-current |
|
Current |
Non-current |
| |
|
|
||||||
|
Nickel forwards - cash flow
hedges, in tonnes |
2,971 |
8,813 |
11,784 |
3,429 |
12,128 |
15,557 |
|
Nickel forwards - held for
trading, in tonnes |
1,763 |
- |
1,763 |
404 |
- |
404 |
|
Zinc forwards - held for
trading, in tonnes |
13,652 |
19,927, |
33,579 |
7,458 |
30,559 |
38,017 |
|
Interest rate swaps - held for
trading, in EUR'000 |
- |
36,636 |
36,636 |
- |
36,636 |
36,636 |
|
Currency forwards - held for
trading, in USD '000 |
127,625 |
32,062 |
159,687 |
- |
- |
- |
|
Currency options - held for
trading, in USD'000 |
64,000 |
- |
64,000 |
209,800 |
- |
209,800 |
|
Borrowings |
||||||
|
|
|
|
||||
|
(all amounts in EUR '000) |
Carrying amount |
Fair value |
||||
|
|
Unaudited |
Audited |
Unaudited |
Audited |
||
|
|
30 Sep |
31 Dec |
30 Sep |
31 Dec |
||
|
Non-current |
2009 |
2008 |
2009 |
2008 |
||
|
Capital loans |
1,405 |
1,405 |
1,405 |
1,405 |
||
|
Project Term Loan Facility |
209,656 |
229,935 |
209,656 |
229,935 |
||
|
Senior Unsecured Convertible
Bonds |
74,813 |
72,842 |
74,813 |
72,842 |
||
|
Railway Term Loan Facility |
30,347 |
25,461 |
30,347 |
25,461 |
||
|
Working capital loan |
44,403 |
- |
44,403 |
- |
||
|
Finance lease liabilities |
13,734 |
1,694 |
13,734 |
1,694 |
||
|
Interest Subsidy Loans |
4,186 |
4,182 |
4,186 |
4,182 |
||
|
Other |
34,308 |
32,436 |
34,308 |
32,436 |
||
|
|
412,852 |
367,955 |
412,852 |
367,955 |
||
|
Current |
||||||
|
Finance lease liabilities |
1,034 |
199 |
1,034 |
199 |
||
|
Project Term Loan Facility |
8,878 |
- |
8,878 |
- |
||
|
Other |
- |
25 |
- |
25 |
||
|
|
9,912 |
224 |
9,912 |
224 |
||
|
Total borrowings |
422,764 |
368,179 |
422,764 |
368,179 |
||
|
Employee-related key figures |
Three
months to |
Three
months to |
Nine
months to |
Nine
months to |
Twelve
months to | |
|
|
30 Sep
2009 |
30 Sep
2008 |
30 Sep
2009 |
30 Sep
2008 |
31 Dec
2008 | |
|
Wages and salaries |
EUR '000 |
3,062 |
2,722 |
9,912 |
6,247 |
5,756 |
|
Average number of
employees |
277 |
210 |
266 |
158 |
178 | |
|
Number of employees
at the end of the
period |
283 |
229 |
283 |
229 |
239 | |
|
Three
months to |
Three
months to |
Nine
months to |
Nine
months to |
Twelve
months to | |
|
Other figures |
30 Sep
2009 |
30 Sep
2008 |
30 Sep
2009 |
30 Sep
2008 |
31 Dec
2008 |
|
Share options
outstanding at the end
of the period |
4,334,500 |
2,285,000 |
4,334,500 |
2,285,000 |
4,442,500 |
|
Number of shares to
be issued against |
|||||
|
the outstanding share
options |
4,334,500 |
2,285,000 |
4,334,500 |
2,285,000 |
4,442,500 |
|
Rights to vote of
shares to be issued
against |
|||||
|
the outstanding share
options |
1.7% |
1.0% |
1.7% |
1.0% |
2.0% |
|
Three
months
to |
Three
months
to |
Nine
months
to |
Nine
months
to |
Twelve
months
to | |||
|
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 | |||
|
Operating
profit
(loss) |
EUR
'000 |
(15,303) |
(4,955) |
(23,208) |
(9,576) |
(4,296) | |
|
Return on
equity |
(2.7%) |
(2.7%) |
(5.2%) |
(4.6%) |
1.6% | ||
|
Equity-to
assets ratio |
48% |
57.2% |
48% |
57.2% |
48.5% | ||
|
Net interest
bearing debt |
EUR
'000 |
354,130 |
100,131 |
354,130 |
100,131 |
285,467 | |
|
Debt-to
equity
ratio |
84.2% |
28.3% |
84.2% |
28.3% |
67.3% | ||
|
Capital
expenditure |
EUR
'000 |
24,315 |
100,128 |
82,052 |
273,030 |
429,086 | |
|
Research &
development
expenditure |
EUR
'000 |
- |
- |
- |
- |
181 | |
|
Property,
plant and
equipment |
EUR
'000 |
615,194 |
401,794 |
615,194 |
401,794 |
552,458 | |
|
Derivative
financial
instruments |
EUR
'000 |
64,975 |
74,393 |
64,975 |
74,393 |
152,545 | |
|
Borrowings |
EUR
'000 |
422,764 |
193,160 |
422,764 |
193,160 |
368,179 | |
|
Cash and
cash
equivalents
at the end
of the period |
EUR
'000 |
68,624 |
93,028 |
68,624 |
93,028 |
82,713 | |
|
Three
months
to |
Three
months
to |
Nine
months
to |
Nine
months
to |
Twelve
months
to | |||
|
Share-
related
key figures |
30 Sep 09 |
30 Sep 09 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 | ||
|
Earnings per
share |
EUR |
(0.04) |
(0.03) |
(0.08) |
(0.05) |
0.03 | |
|
Equity per
share |
EUR |
1.75 |
1.49 |
1.75 |
1.49 |
1.74 | |
|
Development
of share
price at
London
Stock
Exchange |
|||||||
|
Average
trading
price1 |
EUR |
4.27 |
3.60 |
3.39 |
4.27 |
3.64 |
|
|
GBP |
3.72 |
2.86 |
3.00 |
3.34 |
2.90 |
||
|
Lowest
trading
price1 |
EUR |
3.70 |
2.96 |
1.45 |
3.01 |
1.22 |
|
|
GBP |
3.23 |
2.35 |
1.29 |
2.35 |
0.98 |
||
|
Highest
trading
price1 |
EUR |
4.78 |
4.45 |
4.71 |
5.74 |
5.64 |
|
|
GBP |
4.17 |
3.54 |
4.17 |
4.49 |
4.49 |
||
|
Trading
price at
the end of
the period2 |
EUR |
4.18 |
2.97 |
4.18 |
2.97 |
1.25 |
|
|
GBP |
3.80 |
2.35 |
3.80 |
2.35 |
1.19 |
||
|
Change
during the
period |
11.7% |
(36.4%) |
219.1% |
(21.7%) |
(60.3%) |
||
|
Market
capitalization
at the end
of the
period3 |
EUR
'000 |
1,023,794 |
662,796 |
1,023,794 |
662,796 |
278,475 |
|
|
GBP
'000 |
930,936 |
523,807 |
930,936 |
523,807 |
265,247 |
||
|
Development
in trading
volume |
|||||||
|
Trading
volume |
1000
shares |
35,736 |
24,694 |
119,239 |
63,463 |
84,780 |
|
|
In relation to
weighted
average
number of
shares |
15.5% |
11.1% |
51.9% |
28.5% |
38.0% |
||
|
Development
of share
price at OMX
Helsinki |
|||||||
|
Average
trading price |
EUR |
4.38 |
4.19 |
||||
|
Lowest
trading price |
EUR |
3.75 |
3.05 |
||||
|
Highest
trading price |
EUR |
4.86 |
4.86 |
||||
|
Trading price
at the
end of the
period |
EUR |
4.18 |
4.18 |
||||
|
Change
during
the period |
3.2% |
33.5% |
|||||
|
Market
capitalization
at the end of
the period |
EUR
'000 |
931,708 |
931,708 |
||||
|
Development
in trading
volume |
|||||||
|
Trading
volume |
1000
shares |
45,054 |
86.452 |
||||
|
In relation to
weighted
average
number of
shares |
19.6% |
37.6% |
|||||
|
Adjusted
average
number of
shares |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 | ||
|
Number of
shares at
the end of
the period |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 | ||
|
|
|
|
Return on equity |
Profit (loss) for the period/ |
|
(Total equity at the beginning of period +
Total equity at the end of period)/2 | |
|
Equity-to-assets ratio |
Total equity/ |
|
Total assets | |
|
Net interest-bearing debt |
Interest-bearing debt - Cash and cash equivalent |
|
Debt-to-equity ratio |
Net interest-bearing debt/ |
|
Total equity | |
|
Share-related key figures |
|
|
Earnings per share |
Profit (loss) attributable to equity holders of the Company/ |
|
Adjusted average number of shares | |
|
Equity per share |
Equity attributable to equity holders of the Company/ |
|
Adjusted average number of shares | |
|
Market capitalization at the
end of the period |
Number of shares at the end of the period * trading price
at the end of the period |